Saudi Arabia RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

Saudi Arabia RUO Immunoassay Market Size:

Saudi Arabia RUO immunoassay market is expected to grow at a CAGR of 12.88% from 2025 to 2030.

Saudi Arabia RUO Immunoassay Market Trends:

Saudi Arabia continues to expand its biomedical research through various government initiatives under Vision 2030 like the Saudi Human Genome Program. This will lead to a growth in demand for high-quality RUO immunoassays for drug development, studying biomarkers, and understanding disease mechanisms.

The General Authority for Statistics conducted the Research and Development Statistics Survey 2022 of Saudi Arabia exhibited that R&D expenditure reached 19.2 billion SAR (Saudi Riyal) including the private sector accounting for 39% of total expenditure at 7.5 billion SAR, the government sector preceded with 38% at 7.2 billion SAR, and the education sector with 23% at 4.4 billion SAR. Additionally, In 2022, the number of researchers grew to 30.16 thousand. Highest number of researchers were in the educational sector at 89% (26.75 thousand), followed by the private sector at 6% and the government sector at 5% with 1.81 thousand researchers and 1.59 thousand researchers respectively.

Moreover, the diagnostic and detection method for the treatment of individual disease characteristics is gaining momentum and rising focus on research will also lead to a growing requirement for RUO immunoassays. In March 2024, a breakthrough in chronic disease biomarker detection by using biosensing platforms to distinguish cell-free nucleic acids, such as microRNAs and free DNAs was achieved by Saudi professor Dana Al-Sulaiman. This method aims to detect and characterize biomarkers for chronic and age-related diseases by interpreting test results from liquid samples into easily interpretable patterns of dots on a slide, which can detect the presence of cancer.

In 2022, Saudi Arabia launched the first phase of strategy development, revealing the roadmap for Saudi Genome Program (SGP) 2.0. The goal is to establish the Kingdom as a global leader in genomics, focusing on collaborations on genetic diseases, leading in the MENA region, and ensuring genomics plays a crucial role in providing high-quality healthcare to all citizens. This vision aims to revolutionize the future of healthcare.

Saudi Arabia RUO Immunoassay Market Scope:

Report Metric	Details
Saudi Arabia RUO Immunoassay Market Size in 2025	US$8.525 billion
Saudi Arabia RUO Immunoassay Market Size in 2030	US$11.021 billion
Growth Rate	CAGR of 12.88%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Product Type Sample Type Application End-User State
Geographical Segmentation	Riyadh, Mecca, Eastern Region, Others
List of Major Companies in the Saudi Arabia RUO Immunoassay Market	F. Hoffmann-La Roche Ltd QuidelOrtho Corporation Merck KGaA Danaher Corporation Quanterix Corporation
Customization Scope	Free report customization with purchase

 

Saudi Arabia RUO Immunoassay Market Segmentations:

By Product Type

• Immunoassay Kits
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
    • Conventional
    • Manual
  • Radioimmunoassay (RIA Kits)
    • Conventional
    • Manual
  • Chemiluminescent Immunoassay (CLIA) Kits
• Immunoassay Reagents
• Microplate Reader
• Microplates
• Analyzers
  • Automated Analyzers
  • Non-Automated Analyzers
• Microplate Washers
• Others

By Sample Type

• Plasma
• Blood Serum
• Urine
• Saliva
• Cell or Tissue Culture Medium
• Others

By Application

• Oncology
• Blood Screening and Toxicology
• Infectious Disease
• Cardiology
• Allergy Diagnostic
• Rare and Emerging Condition Diagnostic
• Others

By End-User

• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies

By Region

• Riyadh
• Mecca
• Eastern Region
• Others

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

4.1. Product Pipeline

5. SAUDI ARABIA RUO IMMUNOASSAY MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Immunoassay Kits

5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits

5.2.1.1. Conventional 

5.2.1.2. Manual

5.2.2. Radioimmunoassay (RIA Kits)

5.2.2.1. Conventional 

5.2.2.2. Manual

5.2.3. Chemiluminescent Immunoassay (CLIA) Kits

5.3. Immunoassay Reagents

5.4. Microplate Reader

5.5. Microplates

5.6. Analyzers

5.6.1. Automated Analyzers

5.6.2. Non-Automated Analyzers

5.7. Microplate Washers

5.8. Others

6. SAUDI ARABIA RUO IMMUNOASSAY MARKET BY SAMPLE TYPE

6.1. Introduction

6.2. Plasma 

6.3. Blood Serum

6.4. Urine

6.5. Saliva

6.6. Cell or Tissue Culture Medium

6.7. Others

7. SAUDI ARABIA RUO IMMUNOASSAY MARKET BY APPLICATION

7.1. Introduction

7.2. Oncology

7.3. Blood Screening and Toxicology

7.4. Infectious Disease

7.5. Cardiology

7.6. Allergy Diagnostic

7.7. Rare and Emerging Condition Diagnostic

7.8. Others

8. SAUDI ARABIA RUO IMMUNOASSAY MARKET BY END-USER

8.1. Introduction

8.2. Research and Academic Laboratories

8.3. Pharmaceutical and Biotechnology Companies

9. SAUDI ARABIA RUO IMMUNOASSAY MARKET BY REGION

9.1. Introduction

9.2. Riyadh

9.2.1. By Product Type

9.2.2. By Sample Type

9.2.3. By Application

9.2.4. By End-User

9.3. Mecca

9.3.1. By Product Type

9.3.2. By Sample Type

9.3.3. By Application

9.3.4. By End-User

9.4. Eastern Region

9.4.1. By Product Type

9.4.2. By Sample Type

9.4.3. By Application

9.4.4. By End-User

9.5. Others

9.5.1. By Product Type

9.5.2. By Sample Type

9.5.3. By Application

9.5.4. By End-User

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. F. Hoffmann-La Roche Ltd

11.2. QuidelOrtho Corporation

11.3. Merck KGaA

11.4. Danaher Corporation

11.5. Quanterix Corporation

11.6. Thermo Fisher Scientific Inc. 

11.7. Becton Dickinson

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

F. Hoffmann-La Roche Ltd

QuidelOrtho Corporation

Merck KGaA

Danaher Corporation

Quanterix Corporation

Thermo Fisher Scientific Inc. 

Becton Dickinson